Cargando…
Molecular Epidemiology of Heart Failure: Translational Challenges and Opportunities
Heart failure (HF) is the end-stage of all heart disease and arguably constitutes the greatest unmet therapeutic need in cardiovascular medicine today. Classic epidemiological studies have established clinical risk factors for HF, but the cause remains poorly understood in many cases. Biochemical an...
Autor principal: | Smith, J. Gustav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058947/ https://www.ncbi.nlm.nih.gov/pubmed/30062185 http://dx.doi.org/10.1016/j.jacbts.2017.07.010 |
Ejemplares similares
-
Translation of Cardiac Myosin Activation With 2-Deoxy-ATP to Treat Heart Failure Via an Experimental Ribonucleotide Reductase-Based Gene Therapy
por: Thomson, Kassandra S., et al.
Publicado: (2016) -
Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022) -
Translational Metabolomics: Current Challenges and Future Opportunities
por: Pinu, Farhana R., et al.
Publicado: (2019) -
Spinal intradural electrodes: opportunities, challenges and translation to the clinic
por: Harland, Bruce, et al.
Publicado: (2023) -
Research Opportunities in Autonomic Neural Mechanisms of Cardiopulmonary Regulation: A Report From the National Heart, Lung, and Blood Institute and the National Institutes of Health Office of the Director Workshop
por: Mehra, Reena, et al.
Publicado: (2022)